Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans’ protection against the virus.

The Russian car maker Avtotor plans to start producing the first batch of electric vehicles of its own design in 2023 and to launch its sales in 2024, founder of the company, Vladimir Shcherbakov told Industry and Trade Minister Denis Manturov on Friday.

In January-August 2021, Ukraine produced 14.48 million tonnes of pig iron, taking the tenth place in the world ranking of pig iron producers, Ukrinform reports with reference to the Ukrmetalurgprom Association.

Fitch Ratings has affirmed Armenia's Long-Term Foreign-Currency Issuer Default Rating (IDR) at 'B+' with a Stable Outlook, the agency said in a statement on Friday, September 24.

The new Rolls-Royce Ghost has made its official debut in Georgia and was presented for the very first time in Tbilisi. The Who-is-Who of the society in the Georgian capital also gathered first impressions during an exclusive evening reception.

Turkish natural gas and power prices are expected to rise by up to 15% next month, four industry sources said, as a global price spike drives up import bills for a country that increasingly relies on gas plants for hydro-generation shortfalls.

Georgia has reported a total of 1,597 new cases of the coronavirus after conducting 34,331 tests over the last 24 hours.

Israel’s flagship airline and two other local carriers demanded that the government provide them with financial and regulatory support, warning that otherwise they could collapse due to the coronavirus pandemic’s effect on the travel industry.

China's central bank on Friday ruled that all financial transactions involving cryptocurrencies are illegal, the latest in a series of regulatory measures to crack down on crypto trading.

The number of foreigners visiting Turkey hit nearly 4 million in August, according to the Culture and Tourism Ministry.

The WHO announced Friday it was recommending a cocktail of monoclonal antibodies manufactured by the US biotech firm Regeneron and marketed by Swiss pharmaceutical giant Roche to treat COVID-19 in certain patients.

The Greek Minister of Tourism, Vasilis Kikilia, announced that €2 million have been allocated for tourism in Evia, the second-largest isle in the country, as tourism throughout the summer season has been successful, and the industry is expected to reach €12 billion in revenues for this year. He also pointed out that there has been an average cost of 20 per cent increase of costs per visitor in the country.

Georgia exported 1,409 tons of knitted goods to Turkey for a total amount of $44.5 million from January through August 2021, Trend reports referring to Georgian National Statistics Office (Geostat).

The national currency depreciated against the US dollar as a result of trading on September 24. The exchange rate was 0.02 tetri, bringing the official value of the dollar to 3.1181 lari.

Amiran Gamkrelidze, head of the National Center for Disease Control, says that if there is not enough coverage of Covid vaccination in the country, the so-called fifth wave will end quite heavily. He says a fifth wave is expected in late November.

According to Amiran Gamkrelidze, head of the National Center for Disease Control, the current rate of wearing a mask is 43%. According to him, the rate should rise to 95%.

Minister of Health Ekaterine Tikaradze claims that no vaccine against covid has been spoiled in Georgia. According to her, about 200,000 doses expire at the end of November, which Georgia is guaranteed to be utilized.

Concentrix, a leading global provider of customer experience (CX) solutions and technology, has announced that it will now be operating a virtual work at the home office from Georgia. The entry of Concentrix to Georgia is expected to bring many new job opportunities to the area as Concentrix brings significant new business from some of the world's leading brands to the growing Georgian market.

4 vaccines against Covid-19 are used in Georgia: AstraZeneca, Pfizer, Sinopharm, and Sinovac.